Filing Details

Accession Number:
0001179110-15-006453
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-20 16:26:04
Reporting Period:
2015-03-29
Filing Date:
2015-04-20
Accepted Time:
2015-04-20 16:26:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1427944 M. James Roach C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
Senior Vp, Development And Chi No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-03-29 6,750 $0.00 113,405 No 4 D Direct
Common Stock Acquisiton 2015-04-16 50,000 $7.41 163,405 No 4 M Direct
Common Stock Disposition 2015-04-16 6,215 $17.08 157,190 No 4 F Direct
Common Stock Disposition 2015-04-16 50,000 $18.70 107,190 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 D Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase stock Acquisiton 2015-04-16 50,000 $0.00 50,000 $7.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
97,500 2012-02-22 2018-02-22 No 4 M Direct
Footnotes
  1. Represents a decrease of 6,750 shares of restricted common stock, $0.0001 par value per share, pursuant to the related restricted stock agreement, as amended, between Mr. Roach and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2014.
  3. Represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related restricted stock agreement, as amended, between Mr. Roach and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.